IIP

Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting

Retrieved on: 
星期四, 五月 23, 2024
Other Health, Research, General Health, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Clinical Trials, Science, Biotechnology, Other Science, Health, Patient, Doctor of Philosophy, CPI, The Cancer Genome Atlas, Survival, Lymphocyte, TIL, Data, TILS, Translational medicine, TME, IPS, Tumor microenvironment, Lung cancer, Therapy, PFS, Senior, AI, Neoplasm, IIP, IP, Biomarker, ASCO, Society, Classification, Haematoxylin, Dip, TCGA, Annual general meeting

Incendia Therapeutics , a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today announced that it will present data in collaboration with PathAI, a leading AI-powered precision pathology company at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, Illinois.

Key Points: 
  • Incendia Therapeutics , a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today announced that it will present data in collaboration with PathAI, a leading AI-powered precision pathology company at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, Illinois.
  • “The data demonstrate the correlation between immune phenotypes predicted from hematoxylin and eosin (H&E)-stained whole slide images and survival following checkpoint inhibitor therapy in non-small cell lung cancer (NSCLC).
  • In the clinical cohort, cancer tumor infiltrating lymphocytes density and fraction of hot epithelial patches were significantly associated with (PFS) (HR=0.64, q=0.04 and HR=0.69, q=0.04, respectively).
  • Notably, in PD-L1(-) patients (N=43, tumor proportion score ≤1%), iIP patients had longer PFS than eIP and dIP patients (HR=0.35, p=0.02).

argenx Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
星期四, 五月 9, 2024
MuSK protein, FDA, ARDA, IND, PDUFA, Medicine, Autoimmunity, Efgartigimod alfa, Glomerulonephritis, CMS, Inflammation, ITP, IIP, ALS, Alfa Romeo, C2, Therapy, Systemic scleroderma, Safety, Euronext, Nektar, DGF, Sjögren syndrome, CIDP, Biology, IL-6, Nektar Therapeutics, GMG, TED, File, MMN, Lupus nephritis, Kidney, AMR, Multifocal motor neuropathy, Patient, Congenital myasthenic syndrome, Immune system, Dermatomyositis, Growth, Amgen, Pharmaceutical industry

“The team at argenx has made significant progress executing across the ambitious plan we set out at the beginning of the year,” said Tim Van Hauwermeiren, Chief Executive Officer of argenx.

Key Points: 
  • “The team at argenx has made significant progress executing across the ambitious plan we set out at the beginning of the year,” said Tim Van Hauwermeiren, Chief Executive Officer of argenx.
  • “We are driven by our commitment to provide patients with the broadest gMG product offering that consistently delivers on safety and efficacy.
  • VYVGART SC played a key role in our growth over the quarter, expanding the breadth of our prescriber base and reaching new patients.
  • In addition, argenx is evaluating ARGX-119, a muscle-specific kinase (MuSK) agonist in both congenital myasthenic syndrome (CMS) and amyotrophic lateral sclerosis (ALS).

Innovative Industrial Properties Reports First Quarter 2024 Results

Retrieved on: 
星期三, 五月 8, 2024
REIT, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Debt-to-GDP ratio, Sale, Lexington Battle Green, Total, Investment, Tenant, Normalization, Webcast, IIP, ATM, FFO, Pleasanton Unified School District, GAAP, RSF, Note

Illinois property (leased to 4Front) – a ground-up cultivation and processing facility comprising 250,000 RSF and $71.8 million in invested/committed capital.

Key Points: 
  • Illinois property (leased to 4Front) – a ground-up cultivation and processing facility comprising 250,000 RSF and $71.8 million in invested/committed capital.
  • The total consideration of $13.0 million exceeded IIP’s net carrying value of the property as of March 31, 2024.
  • IIP paid a quarterly dividend of $1.82 per common share on April 15, 2024 to stockholders of record as of March 28, 2024.
  • Innovative Industrial Properties, Inc. will conduct a conference call and webcast at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) on Thursday, May 9, 2024 to discuss IIP’s financial results and operations for the first quarter ended March 31, 2024.

U.S. Physical Therapy Reports First Quarter 2024 Results

Retrieved on: 
星期二, 五月 7, 2024
Health, Hospitals, Surgery, Physical Therapy, Managed Care, General Health, Corporation, Injury, Sale, Economy, Accountability Act, Weather, Risk, Annual report, Health information technology, Security (finance), Collection, IIP, Omnibus spending bill, Environment, Tax, Government, COVID-19, Privacy, Acquisition, Failure, Medicare, Adjustment, ID, Alternative, GAAP, Interest

Operating income was $14.3 million for the 2024 First Quarter compared to $17.0 million for the 2023 First Quarter.

Key Points: 
  • Operating income was $14.3 million for the 2024 First Quarter compared to $17.0 million for the 2023 First Quarter.
  • Total other income (expense), net, was $0.4 million in the 2024 First Quarter compared to ($2.6) million in the 2023 First Quarter.
  • USPH net income was $8.0 million for the 2024 First Quarter as compared to $7.4 million for the 2023 First Quarter.
  • ET / 9:30 a.m. CT, on May 8, 2024, to discuss the Company’s financial results for the first quarter ended March 31, 2024.

New Jersey Resources Reports Fiscal 2024 Second-Quarter Results

Retrieved on: 
星期二, 五月 7, 2024
Oil, Gas, Alternative Energy, Energy, Other Energy, Utilities, Storm, Sale, Investment, Transport, Safety, CEV, SREC, Depreciation, BGSS, IIP, Capital expenditure, Public expenditure, TREC, BPU, File, GAAP, Operation, NJR

NJNG reported second-quarter fiscal 2024 NFE of $107.1 million, compared to NFE of $100.7 million during the same period in fiscal 2023.

Key Points: 
  • NJNG reported second-quarter fiscal 2024 NFE of $107.1 million, compared to NFE of $100.7 million during the same period in fiscal 2023.
  • Fiscal 2024 year-to-date NFE were $158.5 million, compared to NFE of $155.4 million during the same period in fiscal 2023.
  • NJNG added 4,058 new customers during the first six months of fiscal 2024, compared with 4,064 during the same period of fiscal 2023.
  • Fiscal 2024 year-to-date NFE were $5.6 million, compared with NFE of $8.7 million during the same period in fiscal 2023.

Today’s Digital Age Calls for Increased Protection of the Phone Number, says iconectiv

Retrieved on: 
星期四, 五月 2, 2024
Technology, Mobile, Wireless, Insurance, Finance, Security, Carriers and Services, Telecommunications, Professional Services, Data Management, USD, Intelligence, Attention, Digital, IP, Fintech, Communication, City centre, IIP

Digital identity is the focus of the newly released iconectiv Market Brief: Instantly confirm the identity of mobile numbers for financial services, health care and e-commerce transactions .

Key Points: 
  • Digital identity is the focus of the newly released iconectiv Market Brief: Instantly confirm the identity of mobile numbers for financial services, health care and e-commerce transactions .
  • Encompassing the information and unique attributes of an individual in the online world, a digital identity includes personal data such as physical addresses, IP addresses, biometrics and phone numbers, which are often used for authentication and verification purposes.
  • With mobile phone numbers becoming the primary source of identity for billions of people, they stand out as a ubiquitous and indispensable element of modern identity verification.
  • iconectiv , a trusted provider of secure data exchange platforms and numbering intelligence within the communications ecosystem, offers a digital identity portfolio that leverages the phone number as a key digital identity signal.

U.S. Physical Therapy Announces Acquisitions

Retrieved on: 
星期三, 五月 1, 2024
Other Health, Professional Services, Other Construction & Property, Hospitals, Construction & Property, Other Manufacturing, Other Transport, Human Resources, Transport, Manufacturing, Health, Physical Therapy, Partnership, Acquisition, IIP

Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), announced the acquisition of an IIP services business by one of its primary IIP companies, Briotix Health Limited Partnership (“Briotix”).

Key Points: 
  • Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), announced the acquisition of an IIP services business by one of its primary IIP companies, Briotix Health Limited Partnership (“Briotix”).
  • Briotix purchased 100% of the IIP services business for a total purchase price of approximately $24.0 million.
  • In a separate transaction, USPH also acquired a two-clinic physical therapy practice with approximately $1.0 million in annual revenue, which is being tucked into a larger recently acquired practice.
  • Chris Reading, Chief Executive Officer, said, “We are extremely pleased to announce our industrial injury prevention acquisition today.

IoTeX Becomes Second Fastest EVM-Compatible Chain & Sixth Fastest Blockchain Overall

Retrieved on: 
星期二, 四月 23, 2024
IIP, Environment, Ecosystem, L1, Delegate, SAN, Nifedipine, TPS, Cryptocurrency

SAN FRANCISCO, April 23, 2024 /PRNewswire-PRWeb/ -- IoTeX, a leading modular DePIN blockchain platform, activated its Mainnet v1.14.0, significantly increasing its throughput to up to 1000 transactions per second (TPS). This upgrade positions IoTeX as the sixth fastest blockchain overall and the second fastest among EVM-compatible chains.

Key Points: 
  • SAN FRANCISCO, April 23, 2024 /PRNewswire-PRWeb/ -- IoTeX , a leading modular DePIN blockchain platform, activated its Mainnet v1.14.0 , significantly increasing its throughput to up to 1000 transactions per second (TPS).
  • This upgrade positions IoTeX as the sixth fastest blockchain overall and the second fastest among EVM-compatible chains.
  • The IoTeX blockchain has processed over 114 million transactions and 29.5 million blocks to date.
  • "This performance upgrade is a significant milestone for IoTeX," said Raullen Chai, CEO of IoTeX.

ACE Venture Enterprises, Inc. Announces Planned Acquisition of Vireo Health of New York from Goodness Growth Holdings

Retrieved on: 
星期二, 四月 2, 2024
War on drugs, Goodness, Organization, New Yorker, War, Growth, IIP, Marketing, Television

NEW YORK and MINNEAPOLIS, April 01, 2024 (GLOBE NEWSWIRE) -- ACE Ventures, LLC (“Ace”), a minority-owned business in the State of New York, Ace’s corporate partner, Ace Venture Enterprises, Inc. and Goodness Growth Holdings, Inc. ("Goodness Growth") (CSE: GDNS; OTCQX: GDNSF), today announced that they have executed a binding term sheet whereby Ace plans to acquire assets of Goodness Growth Holdings subsidiary, Vireo Health of New York (“VireoNY”), pending the satisfaction of closing conditions, including secured capital commitments and regulatory approval.

Key Points: 
  • Ace has agreed to assume VireoNY’s financial liabilities, including its operating losses, beginning on April 1, 2024.
  • These activities are expected to be supported initially by a $2.5 million unsecured loan from Goodness Growth to VireoNY.
  • Goodness Growth and Ace anticipate regulatory approval for the transfer of the New York licenses, as well as closing of the VireoNY transaction, to occur by June 30, 2024.
  • Steven Acevedo commented, “We are thrilled to reach this agreement with Goodness Growth and are excited to enter New York’s cannabis industry.

Innovative Industrial Properties Declares First Quarter 2024 Dividends

Retrieved on: 
星期五, 三月 15, 2024
Alternative Medicine, Cannabis, Health, Commercial Building & Real Estate, Natural Resources, Construction & Property, REIT, IIP, Holding company

Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a first quarter 2024 dividend of $1.82 per share of common stock.

Key Points: 
  • Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a first quarter 2024 dividend of $1.82 per share of common stock.
  • The common stock dividends declared for the last twelve months total $7.24 per common share.
  • Additionally, IIP announced today that its board of directors has declared a regular quarterly dividend of $0.5625 per share of IIP’s 9.00% Series A Cumulative Redeemable Preferred Stock.
  • The dividends are payable on April 15, 2024 to stockholders of record at the close of business on March 28, 2024.